Revvity, Inc.

RVTY: NYSE
32Total

Lowest reading is at 2 out of 100. All scores are out of 100.

About The Company

CEO

Dr. Prahlad R. Singh Ph.D.

Market Cap

16.86 Billion USD

Sector

Healthcare

Website

https://www.revvity.com

Last Update

27/09/2026, 17:10:42

Description

Revvity, Inc. provides health sciences solutions, technologies, and services.

Read More

Strongest readings

  • ✔Debt is low at 0.44 times equity
  • ✔Altman-Z score of 3.17 sits above the distress range

Weakest readings

  • ✘Price-to-earnings of 89.4 is above the market average of 19.6
  • ✘Returns on capital have declined over five years (8.32% lower)
  • ✘Earnings and cashflow growth is weak (growth score 2 out of 100)
  • ✘The current price sits above estimated fair value (margin of safety -57.13%)
  • ✘Share count has been rising at 1.11% per year

Key Figures

StatusMetricValueReadingMarket avg
✘
Price / earnings (TTM)
89.41x
19.60x
✘
Margin of safety (DCF)
-57.13%
17.95%
✘
Revenue growth (5y average)
-4.91%
10.97%
✘
Dividend yield (TTM)
0.19%
1.85%
✘
Share count, per year
1.11%
0.00%
✘Return on capital employed3.29%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

27 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
✘
Price / earnings
89.41x
19.60x
✘Free cashflow yield3.04%
4.70%
Price / earnings growthN/A1.50x
Price / book2.33x
—
✘
Margin of safety
-57.13%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 64.78 USD is below the current price of 151.11 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 128.9 USD ✘

Current Price: 151.1 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

2 / 100

Growing more slowly than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
-4.91%
10.97%
✘Earnings growth-25.40%
14.48%
✘Cashflow growth-7.40%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (6.30% against a five year average of -4.91%)
  • ✔Earnings growth has improved this year (-5.06% against a five year average of -25.40%)
  • ✔Free cashflow growth has improved this year

Health

55 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✔Altman-Z score3.17
3.00
✔Piotroski score7.00
5.00
✔Debt / equity0.44x
0.80x
✔Current ratio1.68x
1.00x
✔Interest coverage3.87x
2.50x
✔Free cashflow / debt0.16x
0.15x
✔Debt / capital0.31x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Dividend

    59 / 100

    Covered, with limited headroom.

    StatusMetricValueReadingMarket avg
    ✘
    Dividend yield
    0.19%
    1.85%
    ✘Dividend growth-4.80%
    0.00%
    ✔Payout ratio (earnings)16.60%
    40.00%
    ✔Payout ratio (cashflow)6.27%
    65.00%
    ✔Worst year, last 5 years-0.43%
    -2.00%

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘Dividend growth has been slowing recently

    Management

    42 / 100

    Returns on capital are below the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity3.33%
    15.00%
    ✘Return on capital employed3.29%
    10.00%
    Return on assets1.98%
    —
    Free cashflow return on capital4.70%
    —
    ✘Return on capital, 5y change-8.32%
    0.00%
    ✘
    Share count, per year
    1.11%
    0.00%
    ✔Share count, recent-4.25%
    0.00%
    ✔Realized buyback return7.52%
    0.00%
    ✘Goodwill erosion / equity2.26%
    2.00%
    Price volatility, 5 year33.15%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✔New shares were issued while the value score was 27 out of 100
    • ✘Dividends were raised while earnings fell (dividend 0.60% per year, earnings -25.40% per year)

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    RVTY

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Revvity, Inc.

    Currency

    USD

    Beta

    1.089

    Vol Avg

    1691320

    Ceo

    Dr. Prahlad R. Singh Ph.D.

    Cik

    0000031791

    Cusip

    Exchange

    NYSE

    Full Time Employees

    11000

    Industry

    Diagnostics & Research

    Sector

    Healthcare

    Ipo Date

    Address

    77 4th Avenue

    City

    Waltham

    State

    MA

    Country

    United States

    Zip

    02451

    Phone

    781 663 6900

    Analysis Last Updated

    27/09/2026, 17:10:42

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies